InflaRx IFRX Q4 2025 Earnings Slight EPS Beat Amid PreRevenue Phase ASTI Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Sol Strategies Inc STKE Q1 2026 Earnings Wide EPS Miss Triggers Sharp Selloff Altimmune Inc ALT Q1 2026 Earnings EPS Beat Surprises to the Upside Amid Pipeline Progress SRRK Q1 2026 Earnings WiderthanExpected Loss Amid Clinical Progress MBINN Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Lower